Cargando…
Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
BACKGROUND: The transmissible spongiform encephalopathies, otherwise known as prion diseases, occur following the conversion of the cellular prion protein (PrP(C)) to an alternatively folded, disease-associated isoform (PrP(Sc)). Recent studies suggest that this conversion occurs via a cholesterol-s...
Autores principales: | Bate, Clive, Tayebi, Mourad, Diomede, Luisa, Salmona, Mario, Williams, Alun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556658/ https://www.ncbi.nlm.nih.gov/pubmed/18789130 http://dx.doi.org/10.1186/1741-7007-6-39 |
Ejemplares similares
-
Glimepiride Reduces the Expression of PrP(C), Prevents PrP(Sc) Formation and Protects against Prion Mediated Neurotoxicity
por: Bate, Clive, et al.
Publicado: (2009) -
Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A(2 )activation
por: Bate, Clive, et al.
Publicado: (2008) -
Phospholipase A(2 )inhibitors protect against prion and Aβ mediated synapse degeneration
por: Bate, Clive, et al.
Publicado: (2010) -
Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004) -
Ginkgolides protect against amyloid-β(1–42)-mediated synapse damage in vitro
por: Bate, Clive, et al.
Publicado: (2008)